Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.

Elia J, Wilson Z, La Porta LS, Algon SA, Prowler ML, Cartwright ST, McKenna PA, Laracy S, Takeda T, Borgmann-Winter K.

Expert Rev Clin Pharmacol. 2011 May;4(3):311-28. doi: 10.1586/ecp.11.11. Review.

PMID:
22114778
[PubMed - indexed for MEDLINE]
2.

Transdermal methylphenidate system: old wine in a new bottle.

Bukstein OG.

Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):661-5. doi: 10.1517/17425250902960148. Review.

PMID:
19442029
[PubMed - indexed for MEDLINE]
3.
4.

Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.

Anderson VR, Scott LJ.

Drugs. 2006;66(8):1117-26. Review.

PMID:
16789796
[PubMed - indexed for MEDLINE]
5.

Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting.

Warshaw EM, Paller AS, Fowler JF, Zirwas MJ.

Clin Ther. 2008 Feb;30(2):326-37. doi: 10.1016/j.clinthera.2008.01.022. Review.

PMID:
18343271
[PubMed - indexed for MEDLINE]
6.

MethyPatch Noven.

Sane N, McGough JJ.

Curr Opin Investig Drugs. 2002 Aug;3(8):1222-4. Review.

PMID:
12211419
[PubMed - indexed for MEDLINE]
7.

Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art.

Arnold LE, Lindsay RL, López FA, Jacob SE, Biederman J, Findling RL, Ramadan Y.

Pediatrics. 2007 Nov;120(5):1100-6. Review.

PMID:
17974748
[PubMed - indexed for MEDLINE]
Free Article
8.

Evolution of stimulants to treat ADHD: transdermal methylphenidate.

Patrick KS, Straughn AB, Perkins JS, González MA.

Hum Psychopharmacol. 2009 Jan;24(1):1-17. doi: 10.1002/hup.992. Review.

PMID:
19051222
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.

Ramos-Quiroga JA, Corominas M, Castells X, Bosch R, Casas M.

Expert Rev Neurother. 2009 Aug;9(8):1121-31. doi: 10.1586/ern.09.65. Review.

PMID:
19673602
[PubMed - indexed for MEDLINE]
10.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
[PubMed - indexed for MEDLINE]
11.

Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.

Moen MD, Keam SJ.

CNS Drugs. 2009 Dec;23(12):1057-83. doi: 10.2165/11201140-000000000-00000. Review.

PMID:
19958043
[PubMed - indexed for MEDLINE]
12.

Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents.

Keating GM.

CNS Drugs. 2011 Apr;25(4):333-42. doi: 10.2165/11206730-000000000-00000. Review.

PMID:
21425884
[PubMed - indexed for MEDLINE]
13.

Pharmacologic treatment of attention deficit hyperactivity disorder.

Greenhill LL.

Psychiatr Clin North Am. 1992 Mar;15(1):1-27. Review.

PMID:
1347936
[PubMed - indexed for MEDLINE]
14.

Dexmethylphenidate extended-release capsules for the treatment of attention deficit hyperactivity disorder.

Kowalik S, Minami H, Silva R.

Expert Opin Pharmacother. 2006 Dec;7(18):2547-57. Review.

PMID:
17150008
[PubMed - indexed for MEDLINE]
15.

[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].

Golubchik P, Sever J, Weizman A.

Harefuah. 2011 Oct;150(10):788-90, 814. Review. Hebrew.

PMID:
22111124
[PubMed - indexed for MEDLINE]
16.

Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder.

Jensen P.

J Atten Disord. 2002;6 Suppl 1:S45-56. Review.

PMID:
12685518
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate.

Wolraich ML, Doffing MA.

CNS Drugs. 2004;18(4):243-50. Review.

PMID:
15015904
[PubMed - indexed for MEDLINE]
18.

Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.

Ermer JC, Adeyi BA, Pucci ML.

CNS Drugs. 2010 Dec;24(12):1009-25. doi: 10.2165/11539410-000000000-00000. Review.

PMID:
21090837
[PubMed - indexed for MEDLINE]
19.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
[PubMed - indexed for MEDLINE]
20.

Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.

Brams M, Mao AR, Doyle RL.

Postgrad Med. 2008 Sep;120(3):69-88. doi: 10.3810/pgm.2008.09.1909. Review.

PMID:
18824827
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk